Lung parenchima changes in neurofibromatosis type 1

  • Aleksandra Ilić Clinic for Lung Diseases, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Snežana Raljević Clinic for Lung Diseases, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Tatjana Adžić Clinic for Lung Diseases, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Vesna Škodrić-Trifunović Clinic for Lung Diseases, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Jelena Stanimirović Clinic for Lung Diseases, Clinical Center of Serbia, Belgrade, Serbia
Keywords: neurofibromatoses, diagnosis, lung fibrosis, radiography, tomography, x-ray computed,

Abstract


Introduction. Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease, is one of the most common single-gene disorders (mutation on chromosome 17q) and usually associated with cutaneous, musculoskeletal and neurological disorders in humans. NF1 is generally complicated with one or more neurobehavioral disorders or tumors located in the peripheral nervous system such as neurofibromas, peripheral nerve sheath tumor, pheochromocytoma, etc. In the available medical literature, the thoracic manifestations of NF1 have been rarely described in these patients. There are few reports about intrathoracic neurogenic tumors, kyphoscoliosis, pneumonitis and pulmonary fibrosis in patients with NF1. Case report. A 65-year-old female was admitted to the Intensive Care Unit at the Lung Clinic of Belgrade University Clinical Center of Serbia. The patient’s general condition was poor with shortness of breath and present cyanosis. At the same time, the skin changes similar to NF1 were noticed, which were additionally documented by her medical history and diagnosed as NF1. After the application of noninvasive mechanical ventilation and other emergency respiratory medicine measures, the patient soon felt better. The parenchymal changes were viewed by subsequent X-rays and CT scanning of the thorax. Conclusion. This is a case report presenting the NF1 associated with the abnormality of lung parenchyma established during diagnostic procedures at the Intensive Care Unit, Clinic of Pulmonology.

 

 


References

Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990; 62(1): 187−92.

Huson SM. The neurofibromatosis: classification, clinical fea-tures and genetic counselling. In: Kaufmann D, editor. Neurofi-bromatoses. Monogr Hum Genet. Manchester (UK): Basel & Karger; 2008; 16: 1−20.

Aughenbaugh GL. Thoracic manifestations of neurocutaneous diseases. Radiol Clin North Am 1984; 22(3): 741−56.

Nelepa P, Wolnicka M. Neurofibromatosis type 1 with interstitial pulmonary lesions diagnosed in an adult patient. Pneumonol Allergol Pol 2012; 80(2): 152−7.

Massaro D, Katz S. Fibrosing alveolitis: its occurrence, roentge-nographic, and pathologic features in von Recklinghausen's neurofibromatosis. Am Rev Respir Dis 1966; 93(6): 934−42.

Davies PD. Diffuse pulmonary involvement in Von Reckling-hausen's disease: a new syndrome. Thorax 1963; 18: 198.

Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004; 17(2): 101−5.

Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplège A. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 2001; 137(11): 1421−5.

Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans D, et al. Guidelines for the diagnosis and management of individ-uals with neurofibromatosis 1. J Med Genet 2007; 44(2): 81−8

Published
2017/01/27
Section
Case report